Private Advisor Group, LLC Incyte Corp Transaction History

Private Advisor Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$66.18 - $83.18 $11,581 - $14,556	-175 Reduced 4.29%	3,900 $296,000
Q1 2022 May 12, 2022	BUY	$66.02 - $79.71 $269,031 - $324,818	4,075 New	4,075 $323,000
Q3 2020 Nov 02, 2020	SELL	$85.07 - $109.69 $202,977 - $261,720	-2,386 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$74.18 - $108.93 $59,344 - $87,144	-800 Reduced 25.11%	2,386 $248,000
Q1 2020 May 12, 2020	BUY	$63.18 - $85.97 $27,799 - $37,826	440 Added 16.02%	3,186 $233,000
Q4 2019 Feb 10, 2020	BUY	$73.04 - $95.72 $200,567 - $262,847	2,746 New	2,746 $240,000
Q1 2019 May 13, 2019	SELL	$63.56 - $88.17 $329,939 - $457,690	-5,191 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$58.5 - $69.94 $96,876 - $115,820	-1,656 Reduced 24.19%	5,191 $329,000
Q3 2018 Nov 01, 2018	BUY	$61.75 - $74.23 $230,759 - $277,397	3,737 Added 120.16%	6,847 $473,000
Q2 2018 Aug 09, 2018	SELL	$60.85 - $83.98 $669 - $923	-11 Reduced 0.35%	3,110 $213,000
Q1 2018 May 09, 2018	BUY	$83.06 - $100.98 $259,230 - $315,158	3,121 New	3,121 $261,000
Q4 2017 Feb 07, 2018	SELL	$93.56 - $116.6 $166,256 - $207,198	-1,777 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $193,959 - $245,705	1,777	1,777 $203,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.